Abstract | OBJECTIVE: Studies have shown that low or high serum bicarbonate levels (reflecting metabolic acidosis or alkalosis) are associated with increased all-cause mortality rates in moderate and advanced chronic kidney disease (CKD) cases. Correction of presumed acidosis using sodium bicarbonate, targeting serum levels around 22 mmol/L, has proven to be beneficial in delaying the progression of the disease and provided mortality benefit. A similar prognostic association may exist between uncorrected metabolic acidosis in chronic liver disease. Correcting it with sodium-containing salts may require more interventions due to increased sodium/fluid load. In patients with liver failure, a naturally alkalotic state, where sodium load is a concern, the impact of this intervention is unclear. DESIGN: RESULT: Our analysis revealed a statistically significant association between the need for paracentesis and bicarbonate therapy. Our study has multiple drawbacks, including a retrospective chart review and limitation of data due to single-center patients. CONCLUSION:
|
Authors | Samira Chandra, Sreelakshmi Ravula, Praveen Errabelli, Horace Spencer, Manisha Singh |
Journal | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
(J Ren Nutr)
Vol. 33
Issue 3
Pg. 499-502
(05 2023)
ISSN: 1532-8503 [Electronic] United States |
PMID | 36736470
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Humans
- Bicarbonates
- Retrospective Studies
- Acidosis
(complications, drug therapy)
- Chronic Disease
- Renal Insufficiency, Chronic
- Sodium
- Liver Diseases
(complications)
- Kidney
- Liver Failure
(complications)
|